Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms
Bruce K. Patterson, View ORCID ProfileRam Yogendra, Edgar B. Francisco, Emily Long, Amruta Pise, Eric Osgood, John Bream, Mark Kreimer, Devon Jeffers, Christopher Beaty, Richard Vander Heide, Jose Guevara-Coto, Rodrigo A Mora-Rodríguez
doi: https://doi.org/10.1101/2024.03.24.24304286
Bruce K. Patterson
1IncellDx Inc, San Carlos, CA
Ram Yogendra
2Lawrence General Hospital, Lawrence, MA
Edgar B. Francisco
1IncellDx Inc, San Carlos, CA
Emily Long
1IncellDx Inc, San Carlos, CA
Amruta Pise
1IncellDx Inc, San Carlos, CA
Eric Osgood
3Department of Medicine, St. Francis Medical Center, Trenton, NJ
John Bream
4Department of Emergency Medicine, Novant Health Kernersville Medical Center, Kernersville, NC
Mark Kreimer
5Department of Emergency Medicine, New York Presbyterian Hospital, Brooklyn, NY
Devon Jeffers
6Department of Anesthesiology, Stamford Hospital, CT
Christopher Beaty
1IncellDx Inc, San Carlos, CA
Richard Vander Heide
7Department of Pathology, Marshfield Medical Center, Marshfield, Wi
Jose Guevara-Coto
8Lab of Tumor Chemosensitivity, CIET / DC Lab, Faculty of Microbiology, Universidad de Costa Rica
Rodrigo A Mora-Rodríguez
8Lab of Tumor Chemosensitivity, CIET / DC Lab, Faculty of Microbiology, Universidad de Costa Rica
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted March 24, 2024.
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms
Bruce K. Patterson, Ram Yogendra, Edgar B. Francisco, Emily Long, Amruta Pise, Eric Osgood, John Bream, Mark Kreimer, Devon Jeffers, Christopher Beaty, Richard Vander Heide, Jose Guevara-Coto, Rodrigo A Mora-Rodríguez
medRxiv 2024.03.24.24304286; doi: https://doi.org/10.1101/2024.03.24.24304286
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms
Bruce K. Patterson, Ram Yogendra, Edgar B. Francisco, Emily Long, Amruta Pise, Eric Osgood, John Bream, Mark Kreimer, Devon Jeffers, Christopher Beaty, Richard Vander Heide, Jose Guevara-Coto, Rodrigo A Mora-Rodríguez
medRxiv 2024.03.24.24304286; doi: https://doi.org/10.1101/2024.03.24.24304286
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12543)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4418)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2844)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4172)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6763)
- Radiology and Imaging (1486)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)